Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein
- PMID: 3513191
- PMCID: PMC323193
- DOI: 10.1073/pnas.83.6.1906
Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein
Abstract
A cDNA copy of the G glycoprotein gene of human respiratory syncytial virus (RSV) was placed under control of a vaccinia virus promoter and inserted into the thymidine kinase locus of the vaccinia virus genome. The recombinant vaccinia virus retained infectivity and expressed a 93-kDa protein that migrated with the authentic RSV G glycoprotein upon polyacrylamide gel electrophoresis. Glycosylation of the expressed protein and transport to the cell surface were demonstrated in the absence of other RSV proteins. Cotton rats that were inoculated intradermally with the infectious recombinant virus produced serum antibody to the G glycoprotein that neutralized RSV in vitro. Furthermore, the vaccinated animals were resistant to lower respiratory tract infection upon intranasal inoculation with RSV and had reduced titers of RSV in the nose.
Similar articles
-
Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity.Proc Natl Acad Sci U S A. 1986 Oct;83(19):7462-6. doi: 10.1073/pnas.83.19.7462. Proc Natl Acad Sci U S A. 1986. PMID: 3532115 Free PMC article.
-
Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virus.Vaccine. 1988 Dec;6(6):519-24. doi: 10.1016/0264-410x(88)90104-1. Vaccine. 1988. PMID: 3072795
-
Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses.J Virol. 1988 Oct;62(10):3907-10. doi: 10.1128/JVI.62.10.3907-3910.1988. J Virol. 1988. PMID: 3047432 Free PMC article.
-
Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses.Virus Res. 1988 Aug;11(1):1-15. doi: 10.1016/0168-1702(88)90063-9. Virus Res. 1988. PMID: 2845680 Review.
-
Immunoprophylaxis of infections with respiratory syncytial virus: observations and hypothesis.Rev Infect Dis. 1990 May-Jun;12 Suppl 4:S470-4; discussion S474-5. doi: 10.1093/clinids/12.supplement_4.s470. Rev Infect Dis. 1990. PMID: 2194271 Review.
Cited by
-
Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene.J Virol. 1988 Dec;62(12):4474-80. doi: 10.1128/JVI.62.12.4474-4480.1988. J Virol. 1988. PMID: 3184271 Free PMC article.
-
Expression of the structural proteins of dengue 2 virus and yellow fever virus by recombinant vaccinia viruses.Arch Virol. 1990;115(3-4):251-65. doi: 10.1007/BF01310534. Arch Virol. 1990. PMID: 2260923
-
Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity.J Virol. 1987 Oct;61(10):3163-6. doi: 10.1128/JVI.61.10.3163-3166.1987. J Virol. 1987. PMID: 3305988 Free PMC article.
-
Bovine respiratory syncytial virus protects cotton rats against human respiratory syncytial virus infection.J Virol. 1993 Mar;67(3):1503-10. doi: 10.1128/JVI.67.3.1503-1510.1993. J Virol. 1993. PMID: 8437227 Free PMC article.
-
Immunization with vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects patas monkeys against PIV3 infection.J Virol. 1988 Apr;62(4):1293-6. doi: 10.1128/JVI.62.4.1293-1296.1988. J Virol. 1988. PMID: 2831389 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical